FDA Inspection 803323 — Centrient Pharmaceuticals Spain S.A.
The FDA completed an inspection of Centrient Pharmaceuticals Spain S.A. on September 19, 2012 in Santa Perpetua De Mogoda. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 19, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Santa Perpetua De Mogoda (Spain)